Literature DB >> 8648019

Theophylline: potential antiinflammatory effects in nocturnal asthma.

M Kraft1, J A Torvik, J B Trudeau, S E Wenzel, R J Martin.   

Abstract

BACKGROUND: Recent information suggests that one of the therapeutic properties of theophylline is an antiinflammatory effect.
OBJECTIVE: We evaluated this potential effect of theophylline in eight patients with nocturnal asthma.
METHODS: The study design was a randomized, double-blind, placebo-controlled crossover of 2-week treatment periods, separated by a 1-week washout period. Spirometry and bronchoscopy were performed.
RESULTS: Theophylline, compared with placebo, significantly improved the overnight decrement in lung function. The higher the nocturnal theophylline level, the greater the improvement in lung function. Theophylline also significantly decreased the percentage of neutrophils in the 4:00 AM bronchoalveolar lavage fluid and stimulated leukotriene B4 levels from macrophages obtained at 4:00 AM. The greater change in neutrophils correlated with increasing serum theophylline concentration. Also, the change in leukotriene B4 production was significantly correlated with the theophylline-induced decrement in lavage granulocytes (neutrophils and eosinophils).
CONCLUSION: This study suggests that one action of theophylline is to alter inflammatory cell number and function in nocturnal asthma and that it may do this through an leukotriene B4-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648019     DOI: 10.1016/s0091-6749(96)70191-4

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

Review 1.  [Asthma therapy: combination of topical glucocorticosteroids and theophylline].

Authors:  D Ukena
Journal:  Med Klin (Munich)       Date:  1997-12

2.  Aspirin attenuates the anti-inflammatory effects of theophylline via inhibition of cAMP production in mice with non-eosinophilic asthma.

Authors:  Hyung-Geun Moon; You-Sun Kim; Jun-Pyo Choi; Dong-Sic Choi; Chang Min Yoon; Seong Gyu Jeon; Yong Song Gho; Yoon-Keun Kim
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

Review 3.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 4.  Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?

Authors:  T D Holimon; C C Chafin; T H Self
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Influence of the Circadian System on Disease Severity.

Authors:  Mikhail Litinski; Frank Ajl Scheer; Steven A Shea
Journal:  Sleep Med Clin       Date:  2009-06-01

6.  Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A.

Authors:  A G Mahomed; A J Theron; R Anderson; C Feldman
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

Review 7.  Theophylline. A review of its potential steroid sparing effects in asthma.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

Review 8.  Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.

Authors:  Domenico Spina
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  New clinical applications of xanthine derivatives: modulatory actions on leukocyte survival and function.

Authors:  K Yasui; A Komiyama
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.319

10.  Addition of theophylline or increasing the dose of inhaled corticosteroid in symptomatic asthma: a meta-analysis of randomized controlled trials.

Authors:  Yan Wang; Kexiong Lin; Changzheng Wang; Xiuqing Liao
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.